Bone Cement Glue Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Bone cements and glues are critical biomaterials in orthopedic surgery, used to anchor implants and fill bone defects. The global market is estimated at approximately $1.4-2.5 billion in 2025, with projections extending to 2030-2035 at annual growth rates ranging from 5.25% to 6.9%. PMMA-based formulations dominate current clinical usage, though next-generation alternatives including bioactive ceramics and synthetic polymeric adhesives are emerging.

• •Market valued at roughly $1.4-2.5 billion in 2025, depending on scope
• •Projected CAGR of 5.9-6.9% across industry projections through 2030-2035
• •PMMA-based bone cement remains the dominant product category

An aging global population is fueling demand for joint replacement and spinal fusion procedures, directly increasing bone cement consumption. Advances in minimally invasive surgical techniques and expanding healthcare infrastructure in emerging economies are further supporting market expansion. Growing prevalence of osteoarthritis, osteoporosis, and traumatic fractures across both developed and developing regions is accelerating clinical adoption.

• •Rising prevalence of osteoporosis and osteoarthritis driving joint replacement surgeries
• •Increasing geriatric populations in North America, Europe, and Asia-Pacific
• •Advances in biomaterial formulations improving biocompatibility and mechanical strength

The market spans PMMA bone cement, calcium phosphate cements, bioactive glass, and surgical adhesives/glues. North America currently holds the largest regional share due to advanced healthcare systems and high orthopedic procedure volumes, while Asia-Pacific is expected to grow the fastest due to expanding access and rising medical tourism.

• •PMMA-based cements lead the market, with bioresorbable and calcium phosphate alternatives gaining share
• •North America accounts for a significant share, followed by Europe and Asia-Pacific
• •Asia-Pacific is projected to register the fastest regional growth

What are the recent trends and outlook?

Bioresorbable bone substitutes and smart biomaterials with drug-elution capabilities represent key innovation frontiers. Surgeons and hospitals are increasingly favoring materials that reduce long-term implant failure rates and improve patient recovery times. The market is expected to remain robust through the 2030s as aging demographics, evolving surgical techniques, and rising access to orthopedic care in emerging markets sustain demand growth.

• •Bioresorbable and injectable calcium phosphate cements gaining clinical preference
• •3D-printed patient-specific implants increasingly paired with advanced bone adhesives
• •Dual-energy X-ray and MRI-compatible cement formulations under development